'This tool supports the implementation of recommendations in the NICE guideline on the management of atrial fibrillation (CG180). It supports the use of edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation. It also supports four statements in the NICE quality standard for atrial fibrillation'
National Institute for Health and Care Excellence
Anticoagulation Advisor for Atrial Fibrillation - NICE Endorsed
- Bleeding and Stroke Risk
- Anticoagulation Status
- NICE Guidance (patient specific)
- Treatment options
- Anticoagulant dosing
- Time in Therapeutic Range
In built safety warnings...
- Contraindications to anticoagulation
- Dual anticoagulant/platelet use
- Missing data e.g. patient weight, serum creatinine.
Direct access to patient decision aids
- Example 1
(CHADS VASC 6,HAS BLED 5, Anticoagulation Contraindicated)
- Example 2
(CHADS VASC 2, HAS BLED 3, pre-existing anticoagulant/antiplatelet)